<DOC>
	<DOCNO>NCT00433914</DOCNO>
	<brief_summary>To explore safety , Tolerability immunogenicity two formulation Meningococcal B Recombinant Vaccine administer healthy infant .</brief_summary>
	<brief_title>Safety , Tolerability Immunogenicity Two Different Formulations Meningococcal B Recombinant Vaccine , When Administered Healthy Infants</brief_title>
	<detailed_description />
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>healthy 68 month old infant previous receipt meningococcal B vaccine ; previous ascertain suspected disease cause N meningitidis ; history anaphylactic shock , asthma , urticaria allergic reaction previous vaccination know hypersensitivity vaccine component ; present suspect serious acute chronic disease know suspect autoimmune disease impairment /alteration immune function</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>8 Months</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Meningococcal disease , prevention , vaccination</keyword>
</DOC>